{"_buckets": {"deposit": "e320591c-5c82-4116-9abe-65fe4c0e39ad"}, "_deposit": {"id": "19890", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "19890"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00019890", "sets": ["456", "1158"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Dose Intensive Chemotherapy with Autologous Bone Marrow Transplantation in Breast Cancer (Application of Autologous BMT to Cancer Treatment)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1993-09", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "9", "bibliographicPageEnd": "820", "bibliographicPageStart": "815", "bibliographicVolumeNumber": "107", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Autologous bone marrow transplantation （ABMT） was first introduced in 1979, and by the end of 1991, 61 patients with recurrent/advanced breast cancer were treated with ABMT-supported chemotherapy, and their responses appeared superior to those obtained with conventional chemotherapy. Although there have been some prolonged disease-free survivors and some of them may have been actually cured, these cases have been exceptional. It was thus felt that ABMT-supported chemotherapy should also be applied for patients with mimimum tumor residue with no prior chemotherapy. 59 patients with alleged high risk for recurrence have been enrolled in adjuvant ABMT-supported chemotherapy trial, with the longest follow-up period being 137 months. There were 23 patients who had 10 or more positive lymphnodes, and they showed 38.5% 5 year relapse-free survival（RFS）, which was in contrast to 10.0% in 30 patients treated with conventional postoperative adjuvant therapy. There were 10 patients who had been treated more than 5 years ago, and their 5 year RFS was 50.0% contrasting to 14.0% in 19 control patients. The chemotherapeutic regimen used in adjuvant was rather modest, since death is least acceptable in these situations.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "123312", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Tajima, Tomoo"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "田島, 知郎"}], "nameIdentifiers": [{"nameIdentifier": "123311", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-16"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "107(9)_815-820.pdf", "filesize": [{"value": "1.3 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1300000.0, "url": {"label": "107(9)_815-820.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/19890/files/107(9)_815-820.pdf"}, "version_id": "5e532ce6-6493-4aaa-98dc-50f9ff49d033"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "autologous bone marrow transplantation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "breast cancer chemotherapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "adjuvant chemotherapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "自家骨髄移植", "subitem_subject_scheme": "Other"}, {"subitem_subject": "乳癌化学療法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "乳癌補助化学療法", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)"}, {"subitem_title": "7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1158"], "permalink_uri": "http://hdl.handle.net/10191/37677", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-02-05"}, "publish_date": "2016-02-05", "publish_status": "0", "recid": "19890", "relation": {}, "relation_version_is_last": true, "title": ["7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)"], "weko_shared_id": null}